Publications

5538 Results

Underrepresentation of patients 65 years of age or older in cancer treatment trials

Authors
L Hutchins;J Unger;J Crowley;C Coltman;K Albain
Journal / Conference
New England Journal of Medicine 341:2061-2067
Year
1999
Research Committee(s)
Cancer Survivorship

Alterations in exon 4 of the p53 gene in gastric cancer.

Authors
D Tolbert;AE Noffsinger;GN Stemmermann;CM Fenoglio-Preiser
Journal / Conference
Proc of the American Association for Cancer Research 40:346(#2289)
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Summary of the proceedings of the United States - Japan lung cancer clinical trials summit: San Francisco, California, 20-22 November, 1998.

Authors
BR Leigh;DR Gandara;JJ Crowley;K Furuse;RB Livingston;M Fukushima;CA Coltman Jr
Journal / Conference
Lung Cancer 24:181-191
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-8805, SWOG-9416

Prospective randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIa non-small cell lung cancer: an Intergroup trial (E3590).

Authors
SM Keller;S Adak;H Wagner;A Herskovic;BJ Brooks;MC Perry;RB Livingston;DH Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 18:465a(#1793)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

Results of the Intergroup [Eastern Cooperative Oncology Group (ECOG) and Southwest Oncology Group (SWOG)] prospective randomized study of surgery alone versus continuous hepatic artery infusion of FUDR and continuous systemic infusion of 5FU after hepatic resection for colorectal liver metastases.

Authors
MM Kemeny;S Adak;S Lipsitz;B Gray;J Macdonald;AB Benson III
Journal / Conference
Proc of the American Society of Clinical Oncology 18:264a(#1012)
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8990 (INT-0103) (EST-9288)

Minisatellite instability in gastric cancer

Authors
YE Nikiforov;T Schulte;GN Stemmermann;AN Noffsinger;CM Fenoglio-Preiser
Journal / Conference
Laboratory Investigation 79:81A(#463)
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 20-year results of a Southwest Oncology Group study

Authors
SE Rivkin;S Green;D Lew;H Glucksberg;N Gad-el-Mawla;J Costanzi;B Hoogstraten;J Athens;T Maloney;C Osborne;C Vaughn;S Martino
Journal / Conference
Proc of the American Society of Clinical Oncology 18:69a(#259)
Year
1999
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-Glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group study

Authors
CP Leith;KJ Kopecky;IM Chen;L Eijdems;ML Slovak;TS McConnell;DR Head;J Weick;MR Grever;FR Appelbaum;CL Willman
Journal / Conference
Blood 94(3):1086-1099
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Combined Modality treatment of primary central nervous system lymphoma (PCNSL) RTOG 93-10.

Authors
L DeAngelis;W Seiferheld;S Schold;B Fisher;R Byhardt
Journal / Conference
Proc of the American Society of Clinical Oncology 18:140a(#537)
Year
1999
Research Committee(s)
Brain
Study Number(s)
SWOG-9310 (INT-0143) (RTOG-93-10)

A prospective, randomized comparison of two doses od combination alkyating agents (AA) as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN): preliminary results of CALGB 9082/ SWOG 9114/NCIC MA-13

Authors
W Peters;G Rosner;J Vredenburgh;E Shpall;M Crump;P Richardson;L Marks;C Cirrincione;W Wood;I Henderson;D Hurd;L Norton
Journal / Conference
Proc of the American Society of Clinical Oncology 18:1a(#2)
Year
1999
Research Committee(s)
Breast
Study Number(s)
SWOG-9114 (INT-0163) (CALGB-9082)